{"pub_date": "2016-08-26T09:00:33+0000", "subsection_name": null, "lead_paragraph": "Heather Bresch, defending her company against criticism for sharply increasing the price of the life-saving device, is unapologetic. \u201cI am running a business,\u201d she says.", "print_page": "1", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "THOMAS", "firstname": "Katie", "role": "reported"}], "original": "By KATIE THOMAS"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/08/26/business/27MYLAN/27MYLAN-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/08/26/business/27MYLAN/27MYLAN-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 900, "url": "images/2016/08/26/business/27MYLAN/27MYLAN-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "900", "xlarge": "images/2016/08/26/business/27MYLAN/27MYLAN-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/08/26/business/27MYLAN/27MYLAN-thumbStandard-v2.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/08/26/business/27MYLAN/27MYLAN-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Business Day", "headline": {"print_headline": "Villain? Mylan\u2019s Chief Says She\u2019s No Such Thing", "main": "Painted as EpiPen Villain, Mylan\u2019s Chief Says She\u2019s No Such Thing"}, "source": "The New York Times", "blog": [], "word_count": "1267", "web_url": "http://www.nytimes.com/2016/08/27/business/painted-as-a-villain-mylans-chief-says-shes-no-such-thing.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "Heather Bresch, defending her company against criticism for sharply increasing the price of the life-saving device, is unapologetic. \u201cI am running a business,\u201d she says....", "_id": "57c0053895d0e021d7982bcc", "abstract": "Mylan chief executive Heather Bresch is at center of public outcry over skyrocketing prices for anti-allergy treatment EpiPen, even as she took big pay raise; while defending price increase, Bresch announces company is increasing financial assistance to patients to reduce their out-of-pocket costs", "keywords": [{"rank": "1", "name": "persons", "value": "Bresch, Heather", "is_major": "Y"}, {"rank": "2", "name": "organizations", "value": "Mylan Inc", "is_major": "Y"}, {"rank": "3", "name": "subject", "value": "Prices (Fares, Fees and Rates)", "is_major": "N"}, {"rank": "4", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y"}, {"rank": "5", "name": "subject", "value": "Generic Brands and Products", "is_major": "N"}]}